Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of the KeriFuse® Intramedullary Arthrodesis Implant and Associated Instruments in the Treatment of IP or DIP Arthritis: a Post Market Clinical Follow-up.

NCT06546332 is registered in ClinicalTrials.gov with Keri Medical SA as lead sponsor.

NCT NCT06546332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06546332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of the KeriFuse® Intramedullary Arthrodesis Implant and Associated Instruments in the Treatment of IP or DIP Arthritis: a Post Market Clinical Follow-up.
Lead sponsor
Keri Medical SA
Phase
Observational
Overall status
Active, not recruiting
Start date
July 5, 2022
Completion date
March 31, 2027
Enrollment
97 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis